Two Unstoppable Growth Stocks to Buy with $1,000 Right Now
Sunday, Nov 24, 2024 10:26 am ET
4min read Investing in the stock market can be an exciting and rewarding experience, especially when you find high-growth stocks that can generate significant returns over time. If you have $1,000 to invest and are looking for unstoppable growth stocks, consider adding these two companies to your portfolio.
1. DexCom (DXCM)
DexCom is a medical device company specializing in continuous glucose monitoring (CGM) devices for diabetes care. The company's products have revolutionized diabetes management by enabling real-time tracking of blood sugar levels, helping patients make better-informed decisions about their health.
In recent quarters, DexCom has faced some headwinds, including an unexpected spike in rebate usage and restructuring of its sales teams. However, these challenges are temporary, and the company's strong financial position and continued innovation make it an attractive long-term investment.
In Q3 2024, DexCom's international revenue grew by 12%, while U.S. revenue declined by 2%. Despite these setbacks, the company's net income increased by 12% year over year, demonstrating its resilience and profitability. DexCom has $2.5 billion in cash on hand and brought in approximately $535 million in free cash flow over the past year.
DexCom's recent launch of Stelo, an over-the-counter glucose biosensor, further expands its market reach and is expected to drive future growth. Additionally, the company's diverse use cases for its products, including management of type 1 and type 2 diabetes and prediabetes, position it well to capture a growing market.
2. Revolve Group (RVLV)
Revolve Group is a leading e-commerce fashion retailer that targets a diverse range of brands, from affordable to premier luxury. The company's broad appeal and long-standing marketing partnerships with influencers have enabled it to maintain steady sales growth even in challenging consumer spending environments.
In Q3 2024, Revolve Group's revenue from the Revolve segment grew by 12% year over year, while its in-house luxury brand FWRD held its ground with a less than 0.5% decline. The company's use of AI solutions has also enhanced its platform's effectiveness, contributing to a 5% year-over-year increase in its active customer base.
Revolve Group's trailing 12-month free cash flow of $37.7 million and return on assets of 13.5% reflect its strong financial health. The company's diversified brand strategy and AI-driven platform position it well to continue its growth trajectory in the coming years.
In conclusion, investing in DexCom and Revolve Group with your $1,000 can provide you with exposure to two unstoppable growth stocks that have demonstrated resilience and strong financial performance. Both companies have compelling long-term growth prospects, and their innovative products and services make them attractive investments for those looking to build a diversified portfolio.
As with any investment, it is essential to conduct thorough research and consider your risk tolerance before making a decision. Diversifying your portfolio and maintaining a long-term perspective can help maximize your returns and minimize risks. Keep an eye on these two companies and consider adding them to your portfolio if you share their bullish outlook on the future.
1. DexCom (DXCM)
DexCom is a medical device company specializing in continuous glucose monitoring (CGM) devices for diabetes care. The company's products have revolutionized diabetes management by enabling real-time tracking of blood sugar levels, helping patients make better-informed decisions about their health.
In recent quarters, DexCom has faced some headwinds, including an unexpected spike in rebate usage and restructuring of its sales teams. However, these challenges are temporary, and the company's strong financial position and continued innovation make it an attractive long-term investment.
In Q3 2024, DexCom's international revenue grew by 12%, while U.S. revenue declined by 2%. Despite these setbacks, the company's net income increased by 12% year over year, demonstrating its resilience and profitability. DexCom has $2.5 billion in cash on hand and brought in approximately $535 million in free cash flow over the past year.
DexCom's recent launch of Stelo, an over-the-counter glucose biosensor, further expands its market reach and is expected to drive future growth. Additionally, the company's diverse use cases for its products, including management of type 1 and type 2 diabetes and prediabetes, position it well to capture a growing market.
2. Revolve Group (RVLV)
Revolve Group is a leading e-commerce fashion retailer that targets a diverse range of brands, from affordable to premier luxury. The company's broad appeal and long-standing marketing partnerships with influencers have enabled it to maintain steady sales growth even in challenging consumer spending environments.
In Q3 2024, Revolve Group's revenue from the Revolve segment grew by 12% year over year, while its in-house luxury brand FWRD held its ground with a less than 0.5% decline. The company's use of AI solutions has also enhanced its platform's effectiveness, contributing to a 5% year-over-year increase in its active customer base.
RVLV Total Revenue YoY, Total Revenue
Revolve Group's trailing 12-month free cash flow of $37.7 million and return on assets of 13.5% reflect its strong financial health. The company's diversified brand strategy and AI-driven platform position it well to continue its growth trajectory in the coming years.
In conclusion, investing in DexCom and Revolve Group with your $1,000 can provide you with exposure to two unstoppable growth stocks that have demonstrated resilience and strong financial performance. Both companies have compelling long-term growth prospects, and their innovative products and services make them attractive investments for those looking to build a diversified portfolio.
As with any investment, it is essential to conduct thorough research and consider your risk tolerance before making a decision. Diversifying your portfolio and maintaining a long-term perspective can help maximize your returns and minimize risks. Keep an eye on these two companies and consider adding them to your portfolio if you share their bullish outlook on the future.
